Methylphenidate effects on mice odontogenesis and connections with human odontogenesis.

Autor: Lima, Karol Sartori, Salles, Antônio Eduardo Sparça, de Araújo Costa, Gabriel, Yokoyama, Márjori Frítola, de Paula Ramos, Solange, Paixão-Côrtes, Vanessa Rodrigues, de Lima, Renata Lúcia Leite Ferreira, Salles, Maria José Sparça
Zdroj: Odontology; Apr2021, Vol. 109 Issue 2, p336-348, 13p
Abstrakt: The purpose of this study is to evaluate the effects of Methylphenidate exposure on mice odontogenesis and connect them by bioinformatics with human odontogenesis. Thirty-two pregnant Swiss mice were divided into treated group and control group, which received, respectively, 5 mg/kg of Methylphenidate and saline solution from the 5th to the 17th day of pregnancy. The mouse embryos tooth germs were analyzed through optical microscopy, and the data collected were analyzed statistically by Fisher's exact test. The presence and similarity of Methylphenidate-associated genes (Pharmgkb database) in both organisms and their interaction with dental development genes (AmiGO2 database) were verified on STRING database. Rates of tooth germ malformations were higher in treated than in control group (Control: 18; Treated: 27; p = 0.035). Mouse embryo malformations were connected with 238 interactions between 69 dental development genes with 35 Methylphenidate genes. Fourteen interactions for four Methylphenidate genes with four dental development genes, with human experimental data, were connected with mouse phenotype data. By homology, the interactions and conservation of proteins/genes may indicate similar outcomes for both organisms. The exposure to Methylphenidate during pregnancy affected odontogenesis in mouse embryos and may affect human odontogenesis. The study of malformations in mice, with a bioinformatics approach, could contribute to understanding of the Methylphenidate effect on embryo development. These results may provide novel hypotheses for further testing and reinforce the FDA protocol: as Methylphenidate is included in category C, its use during pregnancy should be considered if the benefits outweigh the risks. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index
Externí odkaz: